Hearing loss in children with HIV/AIDS

Detalhes bibliográficos
Autor(a) principal: Buriti,Ana Karina Lima
Data de Publicação: 2013
Outros Autores: Oliveira,Simone Helena dos Santos, Muniz,Lilian Ferreira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: CoDAS
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822013000600513
Resumo: PURPOSE: To investigate the occurrence of hearing loss in children with HIV and its association with viral load, opportunistic diseases, and antiretroviral treatment. METHODS: A cross-sectional study was carried out with 23 HIV-positive children under care at two specialized centers in João Pessoa, Paraíba, Brazil. Their parents or legal guardians responded to a questionnaire, containing data on the clinical situation and the hearing health of the children, who were then submitted to audiological assessment. We complied with the guidelines for human research contained in the CNE (National Education Council) Resolution number 196/1996. The findings were analyzed through descriptive statistics. RESULTS: We observed that lamivudine (3TC) was the antiretroviral drug most used in 17 (94.4%) patients, followed by Kaletra (KAL), administered in 14 (77.8%) patients, d4T in 11 (61.1%) patients, and zidovudine (AZT) in 7 (38.9%) participants. Otitis was the most frequent opportunistic disease, with 11 (61.1%) cases. In the audiometric examination, we observed 39 (84.8%) ears with hearing loss and 7 (15.2%) normal ears. After the immitance testing, we found five (10.9%) normal ears, characterized by type A tympanometric curves. The other 41 (89.1%) ears were revealed as altered, with predominance of type B curves in 67.4% of the cases. CONCLUSION: There were hearing alterations in children with HIV/AIDS analyzed in this study. Discreet hearing losses were the most occurring. We verified statistically significant associations with the use of antiretroviral therapy and otitis. Therefore, we point out the importance of auditory monitoring and intervention as soon as possible, thus favoring adequate development in language and decreasing possible difficulties in learning and social inclusion.
id SBFA-1_3aa2fbe74c82609ddd24c0c74cb6ef25
oai_identifier_str oai:scielo:S2317-17822013000600513
network_acronym_str SBFA-1
network_name_str CoDAS
repository_id_str
spelling Hearing loss in children with HIV/AIDSHearing lossHighly active antiretroviral therapyAcquired immunodeficiency syndromeOtitisHearing PURPOSE: To investigate the occurrence of hearing loss in children with HIV and its association with viral load, opportunistic diseases, and antiretroviral treatment. METHODS: A cross-sectional study was carried out with 23 HIV-positive children under care at two specialized centers in João Pessoa, Paraíba, Brazil. Their parents or legal guardians responded to a questionnaire, containing data on the clinical situation and the hearing health of the children, who were then submitted to audiological assessment. We complied with the guidelines for human research contained in the CNE (National Education Council) Resolution number 196/1996. The findings were analyzed through descriptive statistics. RESULTS: We observed that lamivudine (3TC) was the antiretroviral drug most used in 17 (94.4%) patients, followed by Kaletra (KAL), administered in 14 (77.8%) patients, d4T in 11 (61.1%) patients, and zidovudine (AZT) in 7 (38.9%) participants. Otitis was the most frequent opportunistic disease, with 11 (61.1%) cases. In the audiometric examination, we observed 39 (84.8%) ears with hearing loss and 7 (15.2%) normal ears. After the immitance testing, we found five (10.9%) normal ears, characterized by type A tympanometric curves. The other 41 (89.1%) ears were revealed as altered, with predominance of type B curves in 67.4% of the cases. CONCLUSION: There were hearing alterations in children with HIV/AIDS analyzed in this study. Discreet hearing losses were the most occurring. We verified statistically significant associations with the use of antiretroviral therapy and otitis. Therefore, we point out the importance of auditory monitoring and intervention as soon as possible, thus favoring adequate development in language and decreasing possible difficulties in learning and social inclusion. Sociedade Brasileira de Fonoaudiologia2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822013000600513CoDAS v.25 n.6 2013reponame:CoDASinstname:Sociedade Brasileira de Fonoaudiologia (SBFA)instacron:SBFA10.1590/S2317-17822013.05000013info:eu-repo/semantics/openAccessBuriti,Ana Karina LimaOliveira,Simone Helena dos SantosMuniz,Lilian Ferreiraeng2014-08-01T00:00:00Zoai:scielo:S2317-17822013000600513Revistahttps://www.codas.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.phpcodas@editoracubo.com.br||revista@codas.org.br2317-17822317-1782opendoar:2014-08-01T00:00CoDAS - Sociedade Brasileira de Fonoaudiologia (SBFA)false
dc.title.none.fl_str_mv Hearing loss in children with HIV/AIDS
title Hearing loss in children with HIV/AIDS
spellingShingle Hearing loss in children with HIV/AIDS
Buriti,Ana Karina Lima
Hearing loss
Highly active antiretroviral therapy
Acquired immunodeficiency syndrome
Otitis
Hearing
title_short Hearing loss in children with HIV/AIDS
title_full Hearing loss in children with HIV/AIDS
title_fullStr Hearing loss in children with HIV/AIDS
title_full_unstemmed Hearing loss in children with HIV/AIDS
title_sort Hearing loss in children with HIV/AIDS
author Buriti,Ana Karina Lima
author_facet Buriti,Ana Karina Lima
Oliveira,Simone Helena dos Santos
Muniz,Lilian Ferreira
author_role author
author2 Oliveira,Simone Helena dos Santos
Muniz,Lilian Ferreira
author2_role author
author
dc.contributor.author.fl_str_mv Buriti,Ana Karina Lima
Oliveira,Simone Helena dos Santos
Muniz,Lilian Ferreira
dc.subject.por.fl_str_mv Hearing loss
Highly active antiretroviral therapy
Acquired immunodeficiency syndrome
Otitis
Hearing
topic Hearing loss
Highly active antiretroviral therapy
Acquired immunodeficiency syndrome
Otitis
Hearing
description PURPOSE: To investigate the occurrence of hearing loss in children with HIV and its association with viral load, opportunistic diseases, and antiretroviral treatment. METHODS: A cross-sectional study was carried out with 23 HIV-positive children under care at two specialized centers in João Pessoa, Paraíba, Brazil. Their parents or legal guardians responded to a questionnaire, containing data on the clinical situation and the hearing health of the children, who were then submitted to audiological assessment. We complied with the guidelines for human research contained in the CNE (National Education Council) Resolution number 196/1996. The findings were analyzed through descriptive statistics. RESULTS: We observed that lamivudine (3TC) was the antiretroviral drug most used in 17 (94.4%) patients, followed by Kaletra (KAL), administered in 14 (77.8%) patients, d4T in 11 (61.1%) patients, and zidovudine (AZT) in 7 (38.9%) participants. Otitis was the most frequent opportunistic disease, with 11 (61.1%) cases. In the audiometric examination, we observed 39 (84.8%) ears with hearing loss and 7 (15.2%) normal ears. After the immitance testing, we found five (10.9%) normal ears, characterized by type A tympanometric curves. The other 41 (89.1%) ears were revealed as altered, with predominance of type B curves in 67.4% of the cases. CONCLUSION: There were hearing alterations in children with HIV/AIDS analyzed in this study. Discreet hearing losses were the most occurring. We verified statistically significant associations with the use of antiretroviral therapy and otitis. Therefore, we point out the importance of auditory monitoring and intervention as soon as possible, thus favoring adequate development in language and decreasing possible difficulties in learning and social inclusion.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822013000600513
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2317-17822013000600513
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S2317-17822013.05000013
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Fonoaudiologia
publisher.none.fl_str_mv Sociedade Brasileira de Fonoaudiologia
dc.source.none.fl_str_mv CoDAS v.25 n.6 2013
reponame:CoDAS
instname:Sociedade Brasileira de Fonoaudiologia (SBFA)
instacron:SBFA
instname_str Sociedade Brasileira de Fonoaudiologia (SBFA)
instacron_str SBFA
institution SBFA
reponame_str CoDAS
collection CoDAS
repository.name.fl_str_mv CoDAS - Sociedade Brasileira de Fonoaudiologia (SBFA)
repository.mail.fl_str_mv codas@editoracubo.com.br||revista@codas.org.br
_version_ 1752122440293548032